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For more than three decades, the NIEHS has been one of the recog-
nized leaders in the world in the study of endocrine disruptors, sub-
stances that mimic or alter hormonal effects in the body. In the 1970s,
NIEHS scientists pioneered research on reproductive toxicity and dis-
covered the hormonal toxicity of diethylstilbestrol (DES), a drug that
for years had been prescribed to women to prevent miscarriage, but
that was shown to later cause cancer and infertility in some of the chil-
dren of these mothers. Clinical researchers used observations from this
basic science to replicate in animal models what was being seen in
patients, ultimately leading to the discontinued use of DES in pregnant
women. Now NIEHS investigators are demonstrating that exposure to
endocrine disruptors such as DES during critical developmental stages
can actually reprogram the genomes of offspring to cause inappropriate
gene expression, resulting in increased susceptibility later in life to dis-
eases such as cancer, as well as to reproductive, metabolic, and develop-
mental disorders. The ability of an environmental compound to induce
an epigenetic disease state spanning several generations has significant
implications for the study of disease origins and consequences of expo-
sure. For this reason the study of endocrine disruptors continues to be a
research priority at the NIEHS.
The NIEHS has been at the forefront of basic research to under-
stand the toxicology of reproductive and developmental health. This
is particularly important in the case of endocrine disruptors, which
act by multiple mechanisms. To discern whether the toxicity of such
chemicals is due to hormonal activity or some other activity of the
compounds, researchers must first understand how estrogens and the
estrogen receptor work at a basic level. Seminal work by NIEHS
researchers has identified new sites of action and biological activities,
developed animal models to show how estrogens work, and shown
how environmental factors might disrupt them. Recent studies have
found a contributing role for estrogen receptor signaling in the ovary
with regards to ovulation, providing the potential for identifying its
effect on subfertility or infertility.
Researchers in the NTP Center for the Evaluation of Risks to
Human Reproduction (CERHR) have evaluated the endocrine-
disrupting effects of seven phthalates, chemicals used in plastics manufac-
ture, and the phytoestrogen genistein, found in soy. The phthalate evalu-
ations have had broad impact, guiding regulatory agencies in making
decisions on these chemicals. For example, the center’s report was in part
the basis of a Consumer Product Safety Commission recommendation
that certain phthalates be removed from mouthing toys (such as teethers
and rattles) due to concerns about children ingesting these chemicals. In
response to a CERHR report on another phthalate used in plastic tub-
ing, the Food and Drug Administration issued guidance pointing out
the potential danger to newborns and infants receiving treatments with
medical devices containing di(2-ethylhexyl) phthalate. The evaluation of
genistein, which included many NIEHS studies on early developmental
exposures, concluded that it produces reproductive and developmental
toxicity, which has prompted recognition and further research on the
potential health effects of environmental estrogens.  In March 2007, the
CERHR will convene an expert panel to determine whether exposure
to bisphenol A, found in many plastics and in the linings of steel food
cans, is a hazard to human development or reproduction. 
The NIEHS will move research on endocrine disruptors forward
by developing sensitive markers of exposure, early biological
response, and genetic susceptibility. New research is considering the
role of endocrine-disrupting chemicals in conditions such as obesity.
NIEHS epidemiologists are also looking at global populations to
determine whether environmental estrogens affect fertility, reproduc-
tion, or the onset of puberty. For example, researchers have found
that chemicals such as polychlorinated biphenyls and DDT may
affect body size and advance some of the early changes in girls at
puberty. NIEHS scientists are developing an animal model to evalu-
ate the toxic effects of environmental agents on the prostate. And
other ongoing investigations are elucidating the endocrine-disrupting
effects of naturally occurring substances found in common health
and beauty products. The NIEHS is continuing to collaborate with
Duke University Medical Center and the University of North
Carolina Medical School to support joint reproductive studies, some
of which focus on the effects of endocrine disruptors, as well as work-
ing to build new research partnerships in this area. Studies like these
are at the heart of the new NIEHS Strategic Plan because they com-
pel us to consider how the research we conduct fits into the complex
puzzle of improving human health.
Although we have made significant progress in the study of
endocrine disuptors, we’re still a long way from understanding all of
the health effects of these ubiquitous chemicals. Until we do, the
NIEHS will remain committed to this important area of research,
with its ramifications for generations to come.
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